Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-022386
Filing Date
2025-03-11
Accepted
2025-03-11 06:51:25
Documents
5
Effectiveness Date
2025-03-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm258608d1_s8.htm S-8 38172
2 EXHIBIT 5.1 tm258608d1_ex5-1.htm EX-5.1 6490
3 EXHIBIT 23.1 tm258608d1_ex23-1.htm EX-23.1 2378
4 EX-FILING FEES tm258608d1_ex-filingfees.htm EX-FILING FEES 12915
5 GRAPHIC tm258608d1_ex5-1img001.jpg GRAPHIC 9651
  Complete submission text file 0001104659-25-022386.txt   74544
Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285694 | Film No.: 25725802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)